Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) EBIT Margin (2016 - 2026)

Avanos Medical's EBIT Margin history spans 13 years, with the latest figure at 1.38% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 23440.0% to 1.38% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.78%, a 4882.0% increase, with the full-year FY2025 number at 8.78%, up 4882.0% from a year prior.
  • EBIT Margin hit 1.38% in Q4 2025 for Avanos Medical, up from 0.06% in the prior quarter.
  • Over the last five years, EBIT Margin for AVNS hit a ceiling of 9.14% in Q4 2022 and a floor of 233.02% in Q4 2024.
  • Historically, EBIT Margin has averaged 14.87% across 5 years, with a median of 1.61% in 2021.
  • Biggest five-year swings in EBIT Margin: crashed -23948bps in 2024 and later soared 23440bps in 2025.
  • Tracing AVNS's EBIT Margin over 5 years: stood at 62.57% in 2021, then skyrocketed by 115bps to 9.14% in 2022, then decreased by -29bps to 6.46% in 2023, then plummeted by -3706bps to 233.02% in 2024, then skyrocketed by 101bps to 1.38% in 2025.
  • Business Quant data shows EBIT Margin for AVNS at 1.38% in Q4 2025, 0.06% in Q3 2025, and 42.57% in Q2 2025.